FDA
approval
· 2021-12-13
FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Original Application (Teva Pharmaceuticals USA, Inc.)
Summary
FDA approved Teva's generic version of fluticasone propionate and salmeterol inhalation for the maintenance treatment of asthma and chronic obstructive pulmonar…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for FLUTICASONE PROPIONATE AND SALMETEROL (FLUTICASONE PROPIONATE AND SALMETEROL)